Delivery Order SPE2DR25D2212-SPE2DR26FB9FX
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,696.37 firm fixed-price delivery order for Repatha 140 mg/ml SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion scheduled for November 12, 2025. This competitive award, issued on November 10, 2025, carries no set-aside designation and represents a child order under AmerisourceBergen's broader contract vehicle with DLA. This delivery order falls under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a $42,441.39 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order for a specialty pharmaceutical product used in cardiovascular disease management. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, leveraging...
- The Defense Logistics Agency awarded a delivery order valued at $3,915.78 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of November 6, 2025. This firm fixed price delivery order, awarded on November 5, 2025, represents a non-competitive procurement executed under an existing contract vehicle. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,648.59 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement, particularly for military and veteran healthcare systems. The place of...
- The Defense Logistics Agency awarded a $80,596.93 delivery order contract to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order valued at $16,968.74 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of November 4, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $91,225.90 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive award under an existing contract vehicle. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and a...
- The Defense Logistics Agency awarded a delivery order valued at $84,897.00 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick autoinjector pens. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive, direct fulfillment under an existing contract vehicle. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,386.25 on October 23, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This delivery order is issued under...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9FXDelivery Order
The Defense Logistics Agency awarded a $15,783.62 delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This competitively awarded, firm fixed-price contract is non-set-aside and scheduled for completion by November 14, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains its primary distribution and logistics operations. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for the Defense Health Agency and other military and veteran healthcare systems. Repatha is a specialty cardiovascular medication used for cholesterol management, consistent with the company's portfolio of brand-name pharmaceuticals and medical supplies delivered through competitively awarded DLA contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 11/13/25 |